MarketPeel
Insider Trading Intelligence
Pricing
…
JM

Jonathan L. Marcus

CME
SR MD GENERAL COUNSEL · CME GROUP INC. · CIK 0001952996
FILING MIX · LIFETIME29%/71%
BUYS
5
SELLS
12
TOTAL VALUE
$7.48M
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
7,192
AVG SELL PX
$305.57
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by Jonathan L. Marcus, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%-0.10%-1.14%+1.03%+0.33%—
14d5+40.00%-0.81%-0.71%-0.09%+0.81%—
30d5+60.00%-1.83%+2.08%-3.91%-2.85%—
60d5+60.00%+1.21%+5.90%-4.69%-7.00%—
90d5+60.00%-4.88%+6.84%-11.71%-11.19%—
180d5(2 pending)+0.00%+13.82%+4.98%+8.85%+18.95%—
1y5(4 pending)+0.00%+8.96%+25.21%-16.25%-16.25%—
2y5(5 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CME · 7,192 shares · as of Mar 17, 2026
03,2806,5619,84113,121202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 5 buys / 12 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CME
CME GROUP INC.
SALE10b5-1
10b5-1 plan
3,291$333.37$1.10M7,192Mar 17, 2026Mar 19, 2026 ↗View →
CME
CME GROUP INC.
SALE10b5-1
10b5-1 plan
3,291$313.37$1.03M7,192Mar 17, 2026Mar 23, 2026 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
261$311.40$81.3K10,483Mar 15, 2026Mar 17, 2026 ↗View →
CME
CME GROUP INC.
PURCHASEGRANT
Stock grant
5,270$311.40$1.64M13,121Mar 15, 2026Mar 17, 2026 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
2,377$311.40$740.2K10,744Mar 15, 2026Mar 17, 2026 ↗View →
CME
CME GROUP INC.
SALE10b5-1
10b5-1 plan
392$262.00$102.7K7,851Sep 18, 2025Sep 18, 2025 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
294$259.83$76.4K8,243Sep 16, 2025Sep 17, 2025 ↗View →
CME
CME GROUP INC.
SALE10b5-1
10b5-1 plan
376$258.96$97.4K8,537Sep 16, 2025Sep 17, 2025 ↗View →
CME
CME GROUP INC.
PURCHASEGRANT
Stock grant
2,464$258.83$637.8K8,913Sep 15, 2025Sep 17, 2025 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
259$258.83$67.0K6,449Sep 15, 2025Sep 17, 2025 ↗View →
CME
CME GROUP INC.
SALE10b5-1
10b5-1 plan
390$277.50$108.2K6,708May 20, 2025May 21, 2025 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
269$258.68$69.6K7,098Mar 15, 2025Mar 18, 2025 ↗View →
CME
CME GROUP INC.
PURCHASEGRANT
Stock grant
2,744$218.53$599.6K7,367Sep 16, 2024Sep 17, 2024 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
271$216.99$58.8K4,623Sep 15, 2024Sep 17, 2024 ↗View →
CME
CME GROUP INC.
SALE
Sr MD General Counsel
282$217.50$61.3K4,894Mar 15, 2024Mar 19, 2024 ↗View →
CME
CME GROUP INC.
PURCHASEGRANT
Stock grant
2,540$206.82$525.3K5,176Sep 15, 2023Sep 18, 2023 ↗View →
CME
CME GROUP INC.
PURCHASEGRANT
Stock grant
2,636$182.67$481.5K2,636Mar 15, 2023Mar 17, 2023 ↗View →
Other insiders · CME
Loading peer insiders…
About this filer
CIK 0001952996
ROLE
Sr MD General Counsel
PRIMARY
CME
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001952996DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback